Ownership history in ProShare Advisors LLC Β· 17 quarters on record
This page tracks every 13F SEC filing in which ProShare Advisors LLC reported a position in APOLLO MED HLDGS INC (ASTH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β sourced directly from SEC EDGAR 13F filings.
π ProShare Advisors LLC underperformed the S&P 500 by β21.5% annually on this ASTH position. Timing score: 38% (6/16 decisions correct). Average cost basis: $54.73. Maximum drawdown during holding period: β72.7%.
β Significantly underperformed the S&P 500 by 21.5% ann.
16 quarters analyzed
β οΈ Poor timing β buys often preceded drops, trims preceded rallies.
6 of 16 add/trim decisions correct
Best entry: $31.53 (2024 Q4) Β· Worst: $73.48 (2021 Q4)
πͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.
8 adds Β· 9 trims. Bought during 4 of 10 down-price quarters. π Predominantly trimming β distribution phase.
βοΈ Portfolio weight has remained relatively stable β conviction maintained.
Currently 0.0% of portfolio
β Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ 4 (annualised). Not investment advice.
As of 2025 Q4 β sorted by position size